Travere Therapeutics shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Highbridge Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.6M | 10M | 0.86 |
| 2024-06-30 | $21M | 33M | 0.64 |
| 2024-03-31 | $20B | 31M | 650.70 |
| 2023-12-31 | $19B | 29M | 651.27 |
| 2023-09-30 | $17M | 27M | 0.65 |
| 2023-06-30 | $5.7M | 7.0M | 0.81 |
| 2023-03-31 | $21M | 21M | 0.98 |
| 2022-12-31 | $9.2M | 10M | 0.91 |
| 2022-06-30 | $19M | 19M | 1.00 |
| 2022-03-31 | $20M | 19M | 1.05 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management